Evolutionary Genomics (FNAM) Financial Statements

1 Followers

Evolutionary Genomics Financial Overview

Evolutionary Genomics's market cap is currently $1.33K. The company's EPS TTM is $-0.291; its P/E ratio is ―; Evolutionary Genomics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 12.50K	$ 122.69K	$ 114.81K
Gross Profit	$ -1.02M	$ -1.04M	$ -1.78M	$ -83.14K	$ 114.81K
Operating Income	$ -2.01M	$ -2.88M	$ -2.88M	$ -774.83K	$ -836.80K
EBITDA	$ -913.47K	$ -1.76M	$ -2.47M	$ -734.10K	$ -795.72K
Net Income	$ -1.93M	$ -2.79M	$ -1.71M	$ -793.14K	$ -1.10M
Balance Sheet
Cash & Short-Term Investments	$ 577.07K	$ 214.01K	$ 215.84K	$ 87.14K	$ 159.61K
Total Assets	$ 2.35M	$ 2.93M	$ 3.99M	$ 4.24M	$ 4.39M
Total Debt	$ 3.74M	$ 3.74M	$ 2.25M	$ 0.00	$ 0.00
Net Debt	$ 3.17M	$ 3.53M	$ 2.03M	$ -45.44K	$ -131.41K
Total Liabilities	$ 3.92M	$ 7.33M	$ 5.82M	$ 4.58M	$ 3.99M
Stockholders' Equity	$ -1.57M	$ -4.40M	$ -1.83M	$ -333.73K	$ 403.59K
Cash Flow
Free Cash Flow	$ -640.95K	$ -1.58M	$ -2.30M	$ -625.98K	$ -748.84K
Operating Cash Flow	$ -640.95K	$ -1.58M	$ -2.30M	$ -625.98K	$ -748.84K
Investing Cash Flow	$ 0.00	$ 0.00	$ 147.61K	$ 0.00	$ 0.00
Financing Cash Flow	$ 1.00M	$ 1.58M	$ 2.32M	$ 540.01K	$ -242.37K

Currency in USD

Evolutionary Genomics Earnings and Revenue History

Income Statement >

Evolutionary Genomics Debt to Assets

Balance Sheet >

Evolutionary Genomics Cash Flow

Cash Flow >

Evolutionary Genomics Forecast EPS vs Actual EPS

Earnings >